The plasma derived therapy market share value was USD 22.5 billion in 2023, driven by the advancements in plasma fractionation technologies. The market size is anticipated to grow at a CAGR of 6.9% during the forecast period of 2024-2032 to achieve a value of USD 40.9 billion by 2032. Plasma Derived Therapy: Introduction Plasma-derived therapy is a medical approach that harnesses the...